News
Two new models in the Ophir BeamSquared® product family have been added to the MKS portfolio: The Ophir BeamSquared ...
Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...
Technology Feature Published: October 2005 Flow cytometry smaller and better Laura Bonetta Nature Methods 2, 785–795 (2005) Cite this article ...
Between 2008 and 2023, its oncology immunophenotyping lab saw the number of requests for flow cytometry increase from 3,000 to 8,500 per year, with samples of different types, which can add to the ...
Flow cytometry systems are large units that can provide real-time analysis of thousands of cells every second. Cells are carried and aligned to pass through a light beam single file, then measured ...
Whether antiretroviral therapy (ART) is always completely suppressive, or HIV might continue to replicate at low levels despite ART in some people with HIV (PWH), is still debated. Here, we ...
“I know, I know. What about Rep TV?” Swift wrote on her website, referring to the shorthand for “Reputation (Taylor’s Version),” the anticipated rerelease of her sixth studio album.
Planet Labs delivered a strong Q1, beating on both EPS and revenue, and achieved positive operating cash flow for the first time. Growth is driven by defense and intelligence contracts, with new ...
The 2025 Nissan Armada is all-new, but it remains related to the Infiniti QX80. As with, say, a Chevrolet Tahoe and Cadillac’s Escalade, there are obvious mechanical links between the Nissan and ...
FIRST LOOK: The Puma Hali 1 — Tyrese Haliburton’s 1st signature shoe. 👀 Created by renowned designer Salehe Bembury, @TyHaliburton22 is expected to wear the Hali 1 tonight in the NBA Finals.
This map can be expanded to capture every way you can adjust a material. Each adjustable knob, or parameter, adds a new dimension you can move in on the map. Imagine tracking how quickly the arrow ...
Payroll costs (including for temporary staff) remained stable over the half-year (€113.4 million vs. €113.3 million in the first half of 2023-2024). First-half EBITDA margin came in at 8.6%, similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results